SCHEMBL20200029

SCHEMBL20200029

COC(=O)CN1CCN(CC(=O)OC)CCN(CC(=O)N(CC(=O)O)CC(C)C)CCN(CC(=O)OC)CC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MDM2 Q00987 1/20 0.33
TACR1 P25103 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
SIGMAR1 Q99720 1/20 0.31
MAPT P10636 1/20 0.30
KDM4C Q9H3R0 2/20 0.30
KDM4A O75164 1/20 0.30
PHF8 Q9UPP1 1/20 0.30
KDM2A Q9Y2K7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20187624 0.87 HSD17B10 (0.37) ALDH1A1MEN1KMT2AKDM4EMDM2
SCHEMBL20200024 0.84 KDM4E (0.43) ALDH1A1MEN1KMT2AKDM4EMDM2
SCHEMBL24186561 0.84
SCHEMBL20187511 0.82 CA1 (0.33) ALDH1A1KDM4EMDM2CA12CA1
SCHEMBL20199971 0.81 ALDH1A1 (0.35) ALDH1A1KDM4EMDM2SMN1; SMN2SIGMAR1
SCHEMBL20199840 0.80 TACR1 (0.32) ALDH1A1MEN1KMT2ATACR1SMN1; SMN2
SCHEMBL20200037 0.78 BLM (0.35) ALDH1A1KMT2AKDM4EMDM2TACR1
SCHEMBL24186640 0.78
SCHEMBL20200052 0.78 ALDH1A1 (0.37) ALDH1A1MEN1KMT2AKDM4EMDM2
SCHEMBL20187535 0.77 PLA2G10 (0.35) ALDH1A1MEN1KMT2AKDM4ECA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544964-B1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING Bayer Pharma AG (DE) 2020-06-17 EP disclosed
WO-2018096082-A1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 WO disclosed